Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2009.0098


Targeted Agents and Biomarkers Promises and Pitfalls: Personal Genomics, Bioinformatics and Systems Biology Drive Novel Drugs Discovery and Markers for Personalized Cancer Biomedicine.

Dimitrios H. Roukos, M.D.


Despite advances and standardization of surgery, radiotherapy and chemotherapy, solid cancers kill million of patients worldwide. In 2020, cancer will be the top health problem. How could cancer mortality be improved?

In the early 2000s, targeted therapy and multigene expression profiling research raised overentousiasm for highly effective personalized treatment strategies. But with a few exceptions, such as trastuzumab for HER2-positive cancer, and perhaps two gene expression-based signatures, the expectations have not been met.

Absolutely no surprising. Extensive genetic studies reveal now multiple genetic alterations underlying tumorigenesis. Solid cancers including the most common lung, breast, prostate and colorectal cancer are extremely complex and highly heterogeneous diseases. It becomes increasingly clear we should move away from single gene-based approaches to causal network-based approaches.

Genome-wide association (GWA) studies, genetics and genomics research provide now a plethora of data. But how could the extremely complex “genotype-phenotype cancer map” can be displayed?

This perspective article describe how quantitative genetics, personal genomics, bioinformatics, systems biology and in silico could be integrated into comprehensive causal network approaches. These systematic approaches represent the major hope for a new generation of drugs and response prediction biomarkers.

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €33 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 3 February 2004